Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 61

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 1
Chunk 61
---
Item 1. FINANCIAL STATEMENTS

The Cigna GroupConsolidated Statements of IncomeUnauditedUnauditedThree Months Ended September 30,Nine Months Ended September 30,(In millions, except per share amounts)2025202420252024RevenuesPharmacy revenues$56,054 $48,284 $158,336 $135,421 Premiums9,081 11,436 30,973 34,493 Fees and other revenues4,380 3,889 12,412 10,862 Net investment income233 85 707 696 TOTAL REVENUES69,748 63,694 202,428 181,472 Benefits and expensesPharmacy and other service costs55,530 47,565 157,196 133,488 Medical costs and other benefit expenses7,842 9,527 26,089 28,482 Selling, general and administrative expenses3,362 3,590 11,008 10,979 Amortization of acquired intangible assets436 436 1,280 1,279 TOTAL BENEFITS AND EXPENSES67,170 61,118 195,573 174,228 Income from operations2,578 2,576 6,855 7,244 Interest expense and other(347)(376)(1,046)(1,073)Gain (loss) on sale of businesses38 (87)79 (106)Net investment gains (losses)26 (921)76 (2,805)Income before income taxes2,295 1,192 5,964 3,260 TOTAL INCOME TAXES322 367 950 1,018 Net income1,973 825 5,014 2,242 Less: Net income attributable to noncontrolling interests105 86 291 232 SHAREHOLDERS' NET INCOME$1,868 $739 $4,723 $2,010 Shareholders' net income per shareBasic$7.02 $2.65 $17.65 $7.13 Diluted$6.98 $2.63 $17.52 $7.05 

The accompanying Notes to the Consolidated Financial Statements (unaudited) are an integral part of these statements.

3

The Cigna